PPARA and urinary bladder cancer: Validating early carcinogenicitybiomarkers in rats should also allow developing simple preclinical assays torank the carcinogenic potential of developmental PPAR agonists (Figure 3).Additionally, understanding the mechanisms in rats (Figure 3) would aid inassessing the human relevance of the rat bladder cancer findings [135, 136].